Items where Author is "Hackl, C."

Article

Pizon, M. and Schott, D. and Wagner, B. J. and Boscheck, S. and Pachmann, K. and Aung, T. and Hackl, C. and Harteis, S. (2023) Patient derived xenografts generated from circulating cancer stem cells on chorioallantoic membrane as an alternative pre-clinical model for personalized medicine in pancreatic cancer. ANNALS OF ONCOLOGY, 34. S1165-S1165. ISSN 0923-7534, 1569-8041

Velazquez, G. Filippini and Schiele, S. and Gerken, M. and Neumaier, S. and Hackl, C. and Mayr, P. and Klinkhammer-Schalke, M. and Illerhaus, G. and Schlitt, H. J. and Anthuber, M. and Kroencke, T. and Messmann, H. and Maerkl, B. and Schmid, C. and Trepel, M. and Mueller, G. and Claus, R. and Hackanson, B. (2022) Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer. ESMO OPEN, 7 (3): 100470. ISSN , 2059-7029

Iesalnieks, Igors and Bittermann, T. and Schlitt, H. J. and Hackl, C. (2021) Reversal of end-ileostomy in patients with Crohn's disease. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 36 (10). pp. 2119-2125. ISSN 0179-1958, 1432-1262

Hackl, C. and Brunner, S. M. and Schmidt, K. M. and Schlitt, H. J. (2018) Surgical innovations in treatment of metastatic colorectal cancer. Complexity of metastatic surgery as example for personalized medicine. CHIRURG, 89 (3). pp. 191-196. ISSN 0009-4722, 1433-0385

Walter, I. and Schulz, U. and Vogelhuber, M. and Wiedmann, K. and Endlicher, E. and Klebl, F. and Andreesen, R. and Herr, W. and Ghibelli, L. and Hackl, C. and Wiest, R. and Reichle, A. (2017) Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. MEDICAL ONCOLOGY, 34 (12): 192. ISSN 1357-0560, 1559-131X

da Silva, N. Platz Batista and Beyer, L. P. and Hottenrott, M. C. and Hackl, C. and Schlitt, H. J. and Stroszczynski, C. and Wiggermann, P. and Jung, E. M. (2017) Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 66 (4). pp. 357-368. ISSN 1386-0291, 1875-8622

Hackl, C. and Schacherer, D. and Anders, M. and Wiedemann, L. M. and Mohr, A. and Schlitt, H. J. and Stroszczynski, C. and Tranquart, F. and Jung, E. M. (2016) Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55. ULTRASCHALL IN DER MEDIZIN, 37 (3). pp. 290-296. ISSN 0172-4614, 1438-8782

Lang, S. A. and Moser, C. and Hackl, C. and Fichtner-Feigl, S. and Koehl, G. and Schlitt, H. J. and Geissler, E. K. and Stoeltzing, O. (2010) mTOR inhibition induces IGF-IR and Her2 expression in human gastrointestinal cancer cells via mTORC2 dependant mechanism. ONKOLOGIE, 33 (Suppl2). pp. 152-153. ISSN 0378-584X

Other

Schmidt, K. and Hellerbrand, C. and Hackl, C. and Wagner, C. and Schlitt, H. and Geissler, E. and Lang, S. A. (2018) Inhibition of mTORC2 component RICTOR impairs liver metastasis in an experimental model of malignant melanoma. KARGER, BASEL.

Kirchner, G. and Baier-Kleinhenz, L. and Brunner, S. and Sinner, B. and Weigand, K. and Ruemmle, P. and Hackl, C. and Schlitt, H. J. and Scherer, M. N. (2018) OUTCOME AFTER LIVER TRANSPLANTATION IN 25 PATIENTS WITH ISCHEMIC-LIKE CHOLANGIOPATHY WITH SECONDARY SCLEROSING CHOLANGITIS. WILEY, HOBOKEN.

Heudobler, D. and Rechenmacher, M. and Vogelhuber, M. and Thomas, S. and Pukrop, T. and Hackl, C. and Herr, W. and Ghibelli, L. and Gerner, C. and Reichle, A. (2018) A novel therapeutic pillar, anakoinosis: Tumor tissue as a multi-level design space, a meta-analysis. KARGER, BASEL.

Hackl, C. and Wiedemann, L. and Anders, M. and Schlitt, H. J. and Jung, E. M. (2016) Perfusion kinetic analyses using high resolution contrast enhanced ultrasound can reliably predict therapy effects of metronomic topotecan in preclinical models of colorectal liver metastases. KARGER, BASEL.